3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
2
Sponsor Class
OTHER
72
INDUSTRY
34
OTHER_GOV
2
UNKNOWN
1
NIH
1
NETWORK
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
2
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Neoplastic Cells, Circulating
1
Gastric Adenocarcinoma
1
Interventions
Tamoxifen
10
Docetaxel
8
Trastuzumab
7
Paclitaxel
6
Letrozole
6
Gemcitabine
6
Exercise
6
Control Groups
6
exemestane
5
Indocyanine Green
5
Cyclophosphamide
5
Carboplatin
5
Anastrozole
5
pertuzumab
4
dalpiciclib
4
Vinorelbine
4
Doxorubicin
4
Capecitabine
4
pyrotinib
3
Surgical Procedures, Operative
3
Standard of Care
3
Radiotherapy
3
Radiation
3
Mammography
3
Fulvestrant
3
Cisplatin
3
ferumoxides
2
Zoledronic Acid
2
Tablets
2
Surveys and Questionnaires
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Breast Neoplasms
×
130-nm albumin-bound paclitaxel
×
Clear all
NCT05953909
2023-07-20
ERI-Based-01
Fujian Cancer Hospital
Unknown
120 enrolled
NCT01830244
2017-07-02
Neonab
Barwon Health
Phase 2
Unknown
60 enrolled